From Dallas Express · Dallas Express · · 1m
Tris Pharma Pays Texas $7.5 Million
Texas AG settles $7.5m lawsuit with Tris Pharma over ADHD drug claims.
In brief
Texas AG settles $7.5m lawsuit with Tris Pharma over ADHD drug claims. Tris Pharma agreed to pay Texas $7.5 million after misleading claims about ADHD medication effectiveness. Originally reported by Dallas Express.
Settlement Announcement
Texas Attorney General Ken Paxton reached a $7.5 million settlement with Tris Pharmaceuticals over allegations of misleading ADHD drug claims.
Alleged Misleading Claims
Tris Pharma overstated Dyanavel XR's effectiveness and instructed sales reps to claim it worked faster than competitors with unproven benefits for children.
Settlement Details
The agreement resolves claims that Tris Pharma misrepresented Dyanavel XR's effectiveness to Texas Medicaid providers through false statements.
Attorney General Statement
Paxton stated Tris Pharma is paying millions for misleading folks about ADHD drugs prescribed to children and will continue protecting Texas children.
Settlement Terms
The agreement includes mutual desire to settle amicably and avoids litigation costs while defendants deny all liability and wrongdoing.
What matters most
Tris Pharma agreed to pay Texas $7.5 million after misleading claims about ADHD medication effectiveness.
